ARISAPH PHARMACEUTICALS INC

Profile

Company Names

ARISAPH PHARMACEUTICALS INC

Addresses

100 HIGH STREET #1202, BOSTON, MA 02110

Phone Numbers

617-292-3306

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$10,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2013-10-17 
$10,000,000.00 
$20,000,000.00 
$10,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
BACHOVCHIN 
EXECUTIVE OFFICER, DIRECTOR
ARISAPH PHARMACEUTICALS INC
ROBERT 
 
BALDINI 
DIRECTOR
ACCU-BREAK PHARMACEUTICALS INC   |  ARISAPH PHARMACEUTICALS INC
CLAUDE 
 
BENEDICT 
EXECUTIVE OFFICER
ARISAPH PHARMACEUTICALS INC   |  2C TECH CORP
KEVIN 
 
FERRO 
DIRECTOR
PEARL THERAPEUTICS INC   |  ARISAPH PHARMACEUTICALS INC   |  IMMUSANT, INC.   |  MELINTA THERAPEUTICS, INC. /NEW/
ANTONIO 
 
GOTTO 
DIRECTOR
ARISAPH PHARMACEUTICALS INC
MICHAEL 
 
JAHARIS 
DIRECTOR
ARISAPH PHARMACEUTICALS INC
STEVEN 
 
JAHARIS 
DIRECTOR
PEARL THERAPEUTICS INC   |  ARISAPH PHARMACEUTICALS INC
CHRISTOPHER 
 
KIRITSY 
EXECUTIVE OFFICER, DIRECTOR
AVAXIA BIOLOGICS, INC   |  ARISAPH PHARMACEUTICALS INC   |  PIERIS PHARMACEUTICALS, INC.   |  HTG MOLECULAR DIAGNOSTICS, INC
THOMAS 
 
KOESTLER 
DIRECTOR
PEARL THERAPEUTICS INC   |  ARISAPH PHARMACEUTICALS INC   |  IMMUSANT, INC.
MADIAS 
 
NICOLAOS 
DIRECTOR
ARISAPH PHARMACEUTICALS INC
REX 
 
ROTEN 
DIRECTOR
ARISAPH PHARMACEUTICALS INC
JOSEPH 
 
SUAREZ 
EXECUTIVE OFFICER
ARISAPH PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-11-01
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#